estudio flow semaglutide Two-year effects of in adults with overweight or obesity: the STEP 5 trial Highlights ADA 2024: Estudio FLOW

Similarly, HaVy Ngo-Hamilton, Pharmd.D, pharmacist and clinical consultant at BuzzRx, says she believes in the safety and efficacy of Ozempic when used correctly, but reaffirms that if a healthcare professional is prescribing the drug for weight loss, this is off-label use

Expert Rev Gastroenterol Hepatol 2023;17:27382

Ozempic belongs to a class of medications called GLP-1 receptor agonists

In the body composition substudy, total fat mass reduction reached up to about 26%, and the proportion of lean mass lost was not unusually high for a weight loss of that size

[66] It is gratifying to think that such simple nutritional interventions could make such an amazing difference to a child and familys life